As of today (2025-07-15), the Trailing Annual Dividend Yield of Interpace Biosciences is 0.00%.
The historical rank and industry rank for Interpace Biosciences's Dividend Yield % or its related term are showing as below:
IDXG's Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.47 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Interpace Biosciences Dividend Yield % Historical Data
The historical data trend for Interpace Biosciences's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Interpace Biosciences's Dividend Yield %
For the Diagnostics & Research subindustry, Interpace Biosciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Interpace Biosciences's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Interpace Biosciences's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Interpace Biosciences's Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Interpace Biosciences Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Interpace Biosciences's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features. The company develops and commercializes genomic tests and related first-line assays that can personalize medicine and help improve patient diagnosis and management. Its clinical customers mainly consist of physicians, hospitals, cancer centers, commercial laboratories, pathology groups, and clinics. The various diagnostic tests offered by the company include ThyGeNEXT and ThyraMIRv2 for the detection of thyroid cancer, PancraGEN for pancreatic and biliary cancer, RespriDx for lung cancer, and BarreGEN for the detection of esophageal cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IDXG has been successfully added to your 